{"ts": 1769396793.682168, "content": "[TABLE DATA]\nProgram | Project | Indication | Target | Discovery | Pre-clinical | Phase I | Phase II | Phase III\nHit to Lead | Lead Optimization\nNeurodegeneration | AB-12 po | Alzheimer\u2019s disease | Tau | \nAB-12 iv | Alzheimer\u2019s disease | Tau | \nAB-14 | Amyotrophic lateralsclerosis (ALS) | TDP43 | \nAB-19 | Progressivesupranuclearpalsy (PSP) | Tau | \nAB-16 | Parkinson\u2019s disease | \u03b1-synuclein | \nCancer | AB-31 | Lung | Ras | \nAB-32 | Prostate | AR | \nAB-33 | Pancreatic | p53 | \nAnimal Drug | AB-81 | Dog dementia | Tau | \n[END TABLE]\n\nour science Pipeline SCROLL DOWN Pipeline Pipeline Program Project Indication Target Discovery Pre-clinical Phase I Phase II Phase III Hit to Lead Lead Optimization Neuro degeneration AB-12 po Alzheimer\u2019s disease Tau AB-12 iv Alzheimer\u2019s disease Tau AB-14 Amyotrophic lateral sclerosis (ALS) TDP43 AB-19 Progressive supranuclear palsy (PSP) Tau AB-16 Parkinson\u2019s disease \u03b1-synuclein Cancer AB-31 Lung Ras AB-32 Prostate AR AB-33 Pancreatic p53 Animal Drug AB-81 Dog dementia Tau", "type": "text"}